SHO
1. Ensure that patients are comfortable, writing prescriptions for medications,
as necessary. See above for usual medications.
2. Examine all patients together with registrar before daily ward-round,
completing examination before 8.45 am.
3. Ask patients to be at their beds for 8.45 am.
4. Continue or amend prescriptions for medications as necessary, ensuring
that all patients are dilated for ward-round.
5. Complete prescription for medications on discharge, as appropriate.
All patients should be discharged on topical Chloramphenicol, Betnesol
and either Cyclopentolate or Atropine (depending on degree of inflammation).
6. Write clearly in the notes the approximate date when discharged patients
should be reviewed at their home hospital so that the ward clerk can
telephone the referring hospital. The time to first follow-up visit
is approximately one week after local resection or endoresection, two
weeks after enucleation, ten weeks after insertion of markers, and four
weeks after other operations. If the ward clerk is on vacation, speak
to oncology secretary to organize follow-up at local hospital and at
RLUH.
Registrar
1. Supervise SHO, completing all tasks as necessary.
2. Attend daily ward-round.
Consultant
1. Supervise SHO and registrar.
2. Attend daily ward-round.
3. Write discharge letter.
4. Write comments on pathology reports, for referring ophthalmologist.
5. Arrange follow-up appointments with oncology secretary.
6. On receipt of cytogenetic results, decide on screening for metastatic
disease and co-ordinate screening (i.e. inform patient as previously
agreed with patient with letter to GP, referring ophthalmologist and
oncologist).
7. On detection of metastatic disease, inform patient of diagnosis in
most appropriate manner, and write letters to oncologist, referring
ophthalmologist, and general practitioner).
Oncology Nurse
1. Visit and reassure patients in ward.
2. Advise patients on telephone help-line and support service.
3. Phone each patient within 2 weeks of discharge, as appropriate.
4. Co-ordinate screening for metastatic disease in selected patients
(i.e. telephone patient to discuss letter, arrange for scan of abdomen
to be performed every 6 or 12 months, together with LFT's and other
appropriate blood tests). Scan is to be performed on Thursday on day
of follow-up visit or at local hospital if patient is not attending
RLUH).
5. Counsel patients developing metastatic disease, after they have been
informed by appropriate doctor.
6. Counsel patients about treatment of metastatic disease, or arrange
for such counselling to be given elsewhere.
